Ranbaxy shares recover on value buying after steep falls

Shares in Ranbaxy Laboratories gain as much as 3.3 percent, after falling 26 percent over Friday and Monday following a ban by U.S. drug regulator on more of its products.

"Valuation wise, the stock looks good at these levels. It has fallen a lot and I don't think it will fall beyond 300 rupees," said Suresh Parmar, head, institutional equities at KJMC Capital Markets.

At 10:34 a.m., shares in Ranbaxy were up 2.41 percent at 316.60 rupees, outperforming the broader Nifty, which was up 0.24 percent.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • With a saffron censor, freedom of filmmakers is in grave danger

    The composition of the Central Board of Film Certification (CBFC), recently reconstituted in the wake of the en bloc resignation of the previous panel

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Varun Dutt

<b>Riskfactor</b>: 'Fool'-filled method

The gambler’s fallacy, also known as the Monte Carlo fallacy, ...

Zehra Naqvi

Style must reflect a book’s content

Pakistani writer Bilal Tanweer talks about his book, The Scatter ...

Bubbles Sabharwal

Perfection is a myth

I meet a lot of young people in my line ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture